Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Baxter
Medtronic
Merck
McKinsey

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205488

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 205488 describes NATESTO, which is a drug marketed by Aytu and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. Additional details are available on the NATESTO profile page.

The generic ingredient in NATESTO is testosterone. There are sixty-nine drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the testosterone profile page.
Summary for 205488
Tradename:NATESTO
Applicant:Aytu
Ingredient:testosterone
Patents:4
Formulation / Manufacturing:see details
Pharmacology for NDA: 205488
Mechanism of ActionAndrogen Receptor Agonists
Medical Subject Heading (MeSH) Categories for 205488
Suppliers and Packaging for NDA: 205488
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NATESTO testosterone GEL, METERED;NASAL 205488 NDA Aytu BioScience, Inc. 69654-239 69654-239-01 1 BOTTLE, PUMP in 1 CARTON (69654-239-01) > 60 GEL in 1 BOTTLE, PUMP

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL, METERED;NASALStrength5.5MG/0.122GM ACTUATION
Approval Date:May 28, 2014TE:RLD:No
Patent:  Start TrialPatent Expiration:Feb 4, 2024Product Flag?YSubstance Flag?Delist Request?
Patent:  Start TrialPatent Expiration:Feb 4, 2024Product Flag?YSubstance Flag?Delist Request?
Patent:  Start TrialPatent Expiration:Feb 4, 2024Product Flag?YSubstance Flag?Delist Request?
Patented Use:A METHOD OF TESTOSTERONE REPLACEMENT THERAPY COMPRISING THE STEP OF NASALLY ADMINISTERING TO A PATIENT IN NEED OF SUCH TREATMENT AN EFFECTIVE AMOUNT OF TESTOSTERONE GEL FORMULATION.

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Mallinckrodt
Boehringer Ingelheim
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.